John Heymach, MD, PhD | Authors

John Heymach, MD, PhD, Discusses the Use of Adjuvant Immunotherapy for Patients With NSCLC

July 23, 2021

CancerNetwork® sat down with John Heymach, MD, PhD, at the 2021 American Society of Clinical Oncology Annual Meeting to talk adjuvant immunotherapy for recurrence-free survival in resected non–small cell lung cancer.